These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 11668308

  • 1. Influence of NASCET/ACAS trial eligibility on outcome after carotid endarterectomy.
    Lepore MR, Sternbergh WC, Salartash K, Tonnessen B, Money SR.
    J Vasc Surg; 2001 Oct; 34(4):581-6. PubMed ID: 11668308
    [Abstract] [Full Text] [Related]

  • 2. Is the rationale for carotid angioplasty and stenting in patients excluded from NASCET/ACAS or eligible for ARCHeR justified?
    Illig KA, Zhang R, Tanski W, Benesch C, Sternbach Y, Green RM.
    J Vasc Surg; 2003 Mar; 37(3):575-81. PubMed ID: 12618695
    [Abstract] [Full Text] [Related]

  • 3. Thirty-day morbidity and mortality rates for carotid artery intervention by surgeons who perform both carotid endarterectomy and carotid artery angioplasty and stent placement.
    Ecker RD, Lau T, Levy EI, Hopkins LN.
    J Neurosurg; 2007 Feb; 106(2):217-21. PubMed ID: 17410702
    [Abstract] [Full Text] [Related]

  • 4. Transcervical carotid stenting with flow reversal is safe in octogenarians: a preliminary safety study.
    Alvarez B, Ribo M, Maeso J, Quintana M, Alvarez-Sabin J, Matas M.
    J Vasc Surg; 2008 Jan; 47(1):96-100. PubMed ID: 18060727
    [Abstract] [Full Text] [Related]

  • 5. Carotid endarterectomy in SAPPHIRE-eligible high-risk patients: implications for selecting patients for carotid angioplasty and stenting.
    Mozes G, Sullivan TM, Torres-Russotto DR, Bower TC, Hoskin TL, Sampaio SM, Gloviczki P, Panneton JM, Noel AA, Cherry KJ.
    J Vasc Surg; 2004 May; 39(5):958-65; discussion 965-6. PubMed ID: 15111844
    [Abstract] [Full Text] [Related]

  • 6. Treatment of significant carotid artery stenosis in 1824 patients.
    Mazzaccaro D, Stegher S, Occhiuto MT, Malacrida G, Caldana M, Tealdi DG, Nano G.
    J Cardiovasc Surg (Torino); 2015 Feb; 56(1):107-18. PubMed ID: 23752670
    [Abstract] [Full Text] [Related]

  • 7. Carotid endarterectomy for asymptomatic carotid stenosis in the very elderly.
    Ballotta E, Toniato A, Da Roit A, Lorenzetti R, Piatto G, Baracchini C.
    J Vasc Surg; 2015 Feb; 61(2):382-8. PubMed ID: 25175628
    [Abstract] [Full Text] [Related]

  • 8. Comparison of North American Symptomatic Carotid Endarterectomy Trial and population-based outcomes for carotid endarterectomy.
    Hallett JW, Pietropaoli JA, Ilstrup DM, Gayari MM, Williams JA, Meyer FB.
    J Vasc Surg; 1998 May; 27(5):845-50; discussion 851. PubMed ID: 9620136
    [Abstract] [Full Text] [Related]

  • 9. Carotid endarterectomy after NASCET and ACAS: a statewide study. North American Symptomatic Carotid Endarterectomy Trial. Asymptomatic Carotid Artery Stenosis Study.
    Mayo SW, Eldrup-Jorgensen J, Lucas FL, Wennberg DE, Bredenberg CE.
    J Vasc Surg; 1998 Jun; 27(6):1017-22; discussion 1022-3. PubMed ID: 9652463
    [Abstract] [Full Text] [Related]

  • 10. Endarterectomy or carotid artery stenting: the quest continues.
    van der Vaart MG, Meerwaldt R, Reijnen MM, Tio RA, Zeebregts CJ.
    Am J Surg; 2008 Feb; 195(2):259-69. PubMed ID: 18154764
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety of latest-generation self-expanding stents in patients with NASCET-ineligible severe symptomatic extracranial internal carotid artery stenosis.
    Linfante I, Hirsch JA, Selim M, Schlaug G, Caplan LR, Reddy AS.
    Arch Neurol; 2004 Jan; 61(1):39-43. PubMed ID: 14732618
    [Abstract] [Full Text] [Related]

  • 13. Carotid endarterectomy: who is the high-risk patient?
    Nguyen LL, Conte MS, Reed AB, Belkin M.
    Semin Vasc Surg; 2004 Sep; 17(3):219-23. PubMed ID: 15449244
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial.
    Mas JL, Trinquart L, Leys D, Albucher JF, Rousseau H, Viguier A, Bossavy JP, Denis B, Piquet P, Garnier P, Viader F, Touzé E, Julia P, Giroud M, Krause D, Hosseini H, Becquemin JP, Hinzelin G, Houdart E, Hénon H, Neau JP, Bracard S, Onnient Y, Padovani R, Chatellier G, EVA-3S investigators.
    Lancet Neurol; 2008 Oct; 7(10):885-92. PubMed ID: 18774745
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.